Article | June 23, 2022

MSCs "Versus" Or MSCs "Via" T Cells For Cell & Gene Therapy?

Source: RoosterBio

By Jonathan Carson, RoosterBio

T cells cancer cells

To many biologists and immunologists, the notion that T cells and mesenchymal stromal/stem cells (MSCs) can be compared in the same “ice bucket” sounds, at best, simplistic. Nevertheless, both cell types are indeed routinely measured against each other by regenerative medicine product developers as they “whiteboard” their early concepts and TPPs. As the basis for emerging technology and therapeutic platforms, these two distinct lineages each have unique talents that can be aimed at both overlapping and discrete unmet medical needs. Even more fascinating is how T cells and MSCs don’t have to compete for program time and resources—but can instead work together quite nicely!

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene